Your browser doesn't support javascript.
loading
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial.
Dijkstra, Esmée A; Hospers, Geke A P; Kranenbarg, Elma Meershoek-Klein; Fleer, Joke; Roodvoets, Annet G H; Bahadoer, Renu R; Guren, Marianne G; Tjalma, Jolien J J; Putter, Hein; Crolla, Rogier M P H; Hendriks, Mathijs P; Capdevila, Jaume; Radu, Calin; van de Velde, Cornelis J H; Nilsson, Per J; Glimelius, Bengt; van Etten, Boudewijn; Marijnen, Corrie A M.
Afiliação
  • Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands. Electronic address: e.a.dijkstra@umcg.nl.
  • Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands.
  • Kranenbarg EM; Department of Surgery, Leiden University Medical Center, the Netherlands.
  • Fleer J; Department of Health Sciences, Section Health Psychology, University Medical Center Groningen, University of Groningen, the Netherlands.
  • Roodvoets AGH; Department of Surgery, Leiden University Medical Center, the Netherlands.
  • Bahadoer RR; Department of Surgery, Leiden University Medical Center, the Netherlands.
  • Guren MG; Department of Oncology, Oslo University Hospital, Norway.
  • Tjalma JJJ; Department of General Practice, University Medical Center Groningen, University of Groningen, the Netherlands.
  • Putter H; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, the Netherlands.
  • Crolla RMPH; Department of Surgery, Amphia Hospital, Breda, the Netherlands.
  • Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.
  • Capdevila J; Department of Medical Oncology, Vall Hebron Institute of Oncology (VHIO), Vall Hebron University Hospital, Autonomous University of Barcelona (UAB), Spain.
  • Radu C; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • van de Velde CJH; Department of Surgery, Leiden University Medical Center, the Netherlands.
  • Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, the Netherlands.
  • Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Radiother Oncol ; 171: 69-76, 2022 06.
Article em En | MEDLINE | ID: mdl-35447283

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Infecções Sexualmente Transmissíveis / Segunda Neoplasia Primária Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Infecções Sexualmente Transmissíveis / Segunda Neoplasia Primária Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article